OSM-OSMR signaling amplifies IL-1β-induced inflammatory responses and promotes terminal adipogenic differentiation in GO orbital fibroblasts. This dual regulatory function suggests OSMR as a novel therapeutic target for modulating inflammation and tissue remodeling in GO.
Park et al. (Mon,) studied this question.